Similarly, analysis based on the Genomics of Drug Sensitivity in Cancer (GDSC) database showed a negative correlation between ELFN1 levels and the IC50 values of axitinib, pazopanib, elesclomol, YK 4-279, TW 37, midostaurin, and bleomycin (50 μM) (Supplementary Figure S10B). The gene discussed is ELFN1; the disease is cancer.